Cargando…
Targeted Therapies for Multiple Myeloma
Multiple myeloma continues to be a challenging disorder to treat despite improved therapies and the widespread use of proteasome inhibitors and immunomodulatory drugs. Although patient outcomes have improved, the disease continues to invariably relapse, and in the majority of cases, a cure remains e...
Autores principales: | Leow, Christopher Chang-Yew, Low, Michael Sze Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145732/ https://www.ncbi.nlm.nih.gov/pubmed/33922567 http://dx.doi.org/10.3390/jpm11050334 |
Ejemplares similares
-
MEK inhibitors as a chemotherapeutic intervention in multiple myeloma
por: Chang-Yew Leow, C, et al.
Publicado: (2013) -
Targeted therapy of multiple myeloma
por: Zhou, Shan, et al.
Publicado: (2021) -
Targeting the UPS as therapy in multiple myeloma
por: Chauhan, Dharminder, et al.
Publicado: (2008) -
Molecularly Targeted Therapies in Multiple Myeloma
por: de la Puente, Pilar, et al.
Publicado: (2014) -
Adhesion molecules in multiple myeloma oncogenesis and targeted therapy
por: Bou Zerdan, Maroun, et al.
Publicado: (2022)